Hemoxiparin solution injection 3000IU/0.3ml ampoule #10

Hemoxiparin Composition per ampoule: Dosage 3000 anti-Xa IU/0.3 mL (equivalent to 30mg/0.3 mL) Active substance: Enoxaparin sodium 30 mg; Excipients: Water for injection - up to 0.3 mL. Dosage 4000 anti-Xa IU/0.4 mL (equivalent to 40mg/0.4 mL) Active substance: Enoxaparin sodium 40 mg; Excipients: Water for injection - up to 0.4 mL. Dosage 6000 anti-Xa IU/0.6 mL (equivalent to 60mg/0.6 mL) Active substance: Enoxaparin sodium 60 mg; Excipients: Water for injection - up to 0.6 mL. Indications for use Hemoxiparin® is indicated for use in adults: • Prevention of venous thrombosis and embolism in patients undergoing surgery with moderate and high risk, especially orthopedic and general surgical procedures, including oncological surgery. • Prevention of venous thrombosis and embolism in patients on bed rest with acute medical conditions, including acute heart failure and decompensated chronic heart failure (NYHA class III or IV), respiratory failure, as well as acute infections and increased risk of venous thromboembolism in rheumatic diseases (see "Special Indications"). • Treatment of deep vein thrombosis with or without pulmonary embolism, except for cases of pulmonary embolism requiring thrombolytic therapy or surgery. • Prevention of thrombosis in the extracorporeal circulation system during hemodialysis. Acute coronary syndrome: - Treatment of unstable angina and myocardial infarction without ST-segment elevation in combination with oral acetylsalicylic acid; - Treatment of acute myocardial infarction with ST-segment elevation in patients eligible for medical management or subsequent percutaneous coronary intervention. Method of administration: The drug must not be administered intramuscularly! The pre-filled single-use syringe is ready for use. The drug must not be administered intramuscularly! Subcutaneous administration Injections should preferably be administered with the patient in a sitting or lying position. The injection site should be clearly visible. The optimal injection area is 5-6 cm to the left or right of the navel. Injections should be alternated on the right or left anterolateral or posterolateral surface of the abdomen. Before administering the injection, thoroughly wash hands and the abdominal area where the drug will be injected with soapy water, dry them, and wipe the injection site with an alcohol swab. Insert the needle vertically (not sideways) at a 90-degree angle into the gathered skin fold along its entire length until the injection is complete, holding it between the thumb and index finger. Release the skin fold only after the injection is completed. Do not rub the injection site after administering the drug. Storage conditions: Store at a temperature not exceeding 25°C. Do not freeze. Keep out of reach of children.